CVS Health Ventures led a $33.7 Series B round in AmplifAI.

CVS Health Ventures, a corporate venture capital fund that invests in and partners with high-potential, early-stage companies, led a $33.7 Series B round in AmplifAI, an AI-driven contact center solutions provider, offering a range of services including auto QA, CX intelligence, coaching, and performance management, with participation from LiveOak Ventures and Dallas Venture Partners. This investment will accelerate AmplifAI’s mission to unify human and AI agent performance and deliver best-in-class customer experience at scale.